Safety and efficacy of istradefylline, an adenosine A2A receptor antagonist, as a function of baseline dyskinesia (BL-dyskinesia) in Parkinson's disease (PD): A pooled analysis of 4 studies Meeting Abstract (Web of Science)

cited authors

  • Elmer, L.; Toyama, K.; Parno, J.; Braccia, D.; Ristuccia, R.; Mori, A.

publication date

  • September 1, 2020


published in


start page

  • S393

end page

  • S394


  • 35